School of Medicine
Showing 1-50 of 51 Results
-
Bernardo Bonilauri
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Bonilauri is a highly motivated and dedicated scientist with a steadfast commitment to advancing our understanding of the molecular mechanisms underlying cardiovascular biology. He is also at the forefront of developing innovative therapeutic approaches and driving drug discovery efforts. As a Postdoctoral Research Fellow at the Stanford Cardiovascular Institute, under the mentorship of Dr. Joseph C. Wu, Dr. Bonilauri has the privilege of contributing to groundbreaking research in complex disease modeling systems.
His work spans a diverse range of disciplines, including multi-omics, molecular and cellular biology, tissue engineering, biochemistry, structural biology, and advanced imaging technologies. This integrative approach, coupled with his keen critical thinking skills, positions Dr. Bonilauri to unravel the intricate complexities of cardiac diseases and pioneer novel therapeutic strategies. His research is particularly impactful in addressing rare cardiac conditions such as Transthyretin Cardiac Amyloidosis, where innovative solutions are critically needed. -
Arianne Caudal
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Arianne Caudal is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in cardiac metabolism, disease modeling, and drug discovery. Dr. Caudal received her PhD in Biochemistry from the University of Washington, after conducting thesis work on mitochondrial metabolism and protein-protein interactions in the heart.
-
Ramzi Emanuel Dudum
Masters Student in Health Policy, admitted Autumn 2022
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health. -
Gracia Fahed, MD
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Fahed earned her medical degree from the American University of Beirut (AUB) in Lebanon. She graduated at the top of her class and was recognized for her outstanding academic achievements and compassionate patient care. Over the course of her medical studies, Dr. Fahed concentrated her research on understanding the pathophysiology behind endothelial dysfunction, hypertension and the metabolic syndrome. As a postdoctoral scholar in the Stanford Cardiovascular Institute, she now focuses on left ventricular diastolic dysfunction and early diagnosis of genetic cardiomyopathy, with a specific focus on transthyretin cardiac amyloidosis, a serious yet often overlooked cause of heart failure. Dr. Fahed aims to improve risk-stratification to enhance diagnostic care and improve cardiovascular outcomes.
-
Nerea Jimenez Tellez
Postdoctoral Scholar, Cardiovascular Institute
BioNerea is a Postdoctoral Scholar at Dr. Joseph Wu's lab. She earned her Bachelor's degree in Biochemistry at Universidad Complutense de Madrid (Spain). She was in an exchange program at the University of Saskatchewan (Canada) where she completed her Honours Thesis project on the Regulation of the Metastasis Suppressor Protein CREB3L1 in Dr. Deborah H Anderson's lab. She received her Masters' degree at Universidad de Alcalá (Spain) working at Dr. Isabel Liste Noya's lab on The role of p27Kip1 in the pluripotency and differentiation of dopaminergic neurons. She obtained her Ph.D. in Dr. Naweed Syed's lab studying the Cellular and molecular mechanisms underlying anesthetic-induced cytotoxicity, and their impact on learning and memory. She has received an ATRAC postdoctoral fellowship (Aug 2022 - Aug 2023), an AHA postdoctoral fellowship (Apr 2023 - Sept 2024) and currently holds a TRDRP Postdoctoral Fellowship (Jul 2024 - Jun 2027) titled "Using a human in vitro platform to study the effects of cannabinoids on the cardiovascular system" .
-
Shingo Narita
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
Cardiologist (Japan)
Research expertise: AL amyloid cardiomyopathy, Cardiac regeneration -
Chikage Noishiki, MD, PhD
Postdoctoral Scholar, Cardiovascular Institute
BioDoctor of Philosophy, Nippon Medical School, Tokyo, Japan (2019)
Doctor of Medicine, Dokkyo university, Tochigi, Japan (2010)
Board Certified in Plastic and Reconstructive Surgery, Japan (2020)
Fellowship, Plastic and Reconstructive Surgery, Nippon Medical School, Tokyo, Japan (2016) -
Debarun Patra
Postdoctoral Scholar, Cardiovascular Institute
BioDebarun Patra is a postdoctoral researcher at Stanford Medicine, with a background in inflammation research. His research focuses on bridging cellular disease mechanisms with in vivo pathophysiology to identify novel therapeutic targets. His current work integrates advanced multi-omics tools, induced pluripotent stem cell (iPSC) technology, and animal models to investigate inflammatory and metabolic diseases (inflammatory bowel disease and MASH).
Debarun's doctoral research at IIT Ropar under Dr. Durba Pal was focused on exploring role of obese adipose tissue microenvironment in chronic inflammation and insulin resistance, particularly evaluating the interactions between adipocytes and macrophages. His findings revealed the critical roles of microRNA-210, cyclophilin-A, and Fetuin-A in adipose tissue inflammation and insulin resistance. -
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Wenjuan Zhu
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow